December 16, 2021

ImmuneWatch releases white paper evaluating the effect of mutations gathered in the SARS-COV-2 Omicron variant on T cell immunity

Omicron, the latest SARS-COV-2 variant of concern is characterized by a large number of mutations. In our first white paper, we evaluate the effect of these mutations on T-cell immunity by applying a T-cell receptor (TCR)/epitope interaction model.

Stay up to date

Subscribe to our newsletter to receive useful tips and information.

Thank you! Your submission has been received!

Oups ! Un problème s'est produit lors de l'envoi du formulaire.

Recommended articles

March 23, 2024

ImmuneWatch receives Horizon Europe funding in a new innovative European partnership to tackle hurdles in malaria vaccine development

We are excited to share our recent win in the IMMREP23 Kaggle competition focused on TCR (T-cell receptor) specificity prediction. This win is a testament to our team’s expertise in implementing advanced machine learning in immunology.

March 23, 2024

Press release: Pre-existing immune cells can predict early response to hepatitis B vaccine

“Immunosequencing of T cells, combined with machine learning techniques, may enable scientists to predict which patients will have early, strong protection against hepatitis B infection following vaccination.”